Literature DB >> 18274699

Successful relatively low-dose corticosteroid therapy for diclofenac-induced acute interstitial nephritis with severe renal failure.

Makoto Inoue1, Tetsu Akimoto2, Osamu Saito2, Yasuhiro Ando2, Shigeaki Muto2, Eiji Kusano2.   

Abstract

We report a case of nephrotic syndrome and acute renal failure that developed in a 73-year-old woman after six months of treatment with the non-steroidal anti-inflammatory drug (NSAID) diclofenac. Renal biopsy revealed interstitial nephritis and minimal change nephropathy. Despite discontinuation of treatment with diclofenac, she subsequently became anuric and required hemodialysis for progressive azotemia. Since her anuria was persistent, treatment with prednisone at a dose of 30 mg/day was started. With progressive increase in urine output after the initiation of corticosteroid treatment, a constant decrease in serum creatinine was observed along with improvement of creatinine clearance. In addition, the increased urinary excretion of beta2-microglobulin (beta2MG) and N-acetyl-beta-D-glucosaminidase (NAG) on admission was also improved during the treatment. Our findings suggest that corticosteroid treatment should be reserved for patients with the protracted deterioration of renal function even after discontinuation of offending trigger agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274699     DOI: 10.1007/s10157-008-0039-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  22 in total

Review 1.  Acute tubulointerstitial nephritis.

Authors:  R D Toto
Journal:  Am J Med Sci       Date:  1990-06       Impact factor: 2.378

2.  Reversible membranous nephritis associated with diclofenac.

Authors:  J M Campistol; J Galofre; A Botey; A Torras; L Revert
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

3.  Pathogenesis and therapy of interstitial nephritis.

Authors:  E G Neilson
Journal:  Kidney Int       Date:  1989-05       Impact factor: 10.612

4.  Minimal change nephropathy and interstitial nephritis associated with diclofenac.

Authors:  J Wolters; P J van Breda Vriesman
Journal:  Neth J Med       Date:  1985       Impact factor: 1.422

5.  Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs.

Authors:  J H Brezin; S M Katz; A B Schwartz; J L Chinitz
Journal:  N Engl J Med       Date:  1979-12-06       Impact factor: 91.245

6.  Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.

Authors:  T Révai; G Harmos
Journal:  Wien Klin Wochenschr       Date:  1999-07-09       Impact factor: 1.704

7.  Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy.

Authors:  H Watanabe; H Sanada; S Shigetomi; T Katoh; T Watanabe
Journal:  Nephron       Date:  2000-09       Impact factor: 2.847

8.  Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: mRNA levels, protein expression and urinary loss.

Authors:  Simone Sanna-Cherchi; Maria Luisa Carnevali; Davide Martorana; Paolo Cravedi; Umberto Maggiore; Rossella Alinovi; Achiropita Bovino; Silvia Mattei; Guido Orlandini; Rita Gatti; Mario Savi; Yoshikazu Sado; Tauro M Neri; Landino Allegri
Journal:  Am J Nephrol       Date:  2007-02-15       Impact factor: 3.754

Review 9.  Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy.

Authors:  J L Porile; G L Bakris; S Garella
Journal:  J Clin Pharmacol       Date:  1990-05       Impact factor: 3.126

10.  Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis.

Authors:  C Y Tsai; T H Wu; C L Yu; J Y Lu; Y Y Tsai
Journal:  Nephron       Date:  2000-07       Impact factor: 2.847

View more
  1 in total

1.  Tubulointerstitial Nephritis and Uveitis Syndrome: Are Drugs Offenders or Bystanders?

Authors:  Mutsumi Kawamata; Tetsu Akimoto; Taro Sugase; Naoko Otani-Takei; Takuya Miki; Takahiro Masuda; Takahisa Kobayashi; Shin-Ichi Takeda; Shigeaki Muto; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2016-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.